Relapses for DLBCL and HL patients occur early in the post-treatment course and remain eligible for curative therapies.5 CT, PET, and PET/CT are routinely used for patient monitoring.
5. Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Jonathon B. Cohen,1 Madhusmita Behera,1 Carrie A. Thompson,2 and Christopher R. Flowerscorresponding author1 Blood. 2017 Feb 2; 129(5): 561–564.